Medical Device Licensing, a division of UTEK Europe, is pleased to announce a new pricing model known as ‘Pay-per-Click’ Established to further expand listed opportunities and remove market barriers, this new model is effective from Jan 13th 2010.
The newly introduced Pay-per-Click pricing will create further market efficiencies for Medical Device Licensing and will provide additional opportunities for buyers and sellers to access the platform, thereby creating a larger online IP marketplace.
“In 2009, we spent considerable effort listening to our clients on how we might serve the marketplace better. I believe this pricing change will further extend our lead and continue to make our marketplace the most efficient and highly trafficked online licensing platform in the medical device sector.” Mark McBride, Managing Director of UTEK Pharmalicensing / Medical Device Licensing continues, “Our Pay-per-Click option is intended to remove pricing barriers for users of our service, increasing our base of potential clients. We continue to take as much risk as possible out of our clients’ partner search process, and offer our visitors more opportunities to meet their medical device requirements.”
All new clients will be eligible for the pricing structure, which will enable companies to post their profile and only pay for qualified traffic. Pay-per-Click clients will pay only for the partnering opportunities or potential partner click-throughs they receive. The Company plans to expand the new pricing model to additional licensing platforms which are due to be launched in 2010.
For more information please visit Pay-per-Click page.
As a developer of an innovative product or technology in the pharmaceutical industry it is inevitable that one day you will require the services of a partner.
The Partnering Search service from Medical Device Licensing is designed to move the workload associated with finding partners from you over to us.
Following your instructions and based entirely on your criteria, the Partnering Search Team at Medical Device Licensing will actively search for partners on your behalf and provide you with a qualified list of target companies.
Medical device for targeted topical delivery of liquid, frozen or lyophilized formulations provides an alternative delivery method to syringes.
Our European client has a Class I medical device (CE marked) for the targeted transdermal administration of liquid substances.
More
Infra-red 3D digital imaging, tomography and spectroscopy technology.
US based innovative start-up company is developing a unique 3D infrared digital imaging device for the early detection of breast cancer.
More
Seeking channel partners to expand distribution and marketing of information management software systems and services to Europe’s healthcare industry.
US based company with European based operations seeks channel partners to expand marketing and distribution of its information management software products that are designed and developed for blood banks, transfusion centres, hospitals, laboratories, etc.
More
Medical Device Licensing now offers expert support to assist and guide you through the entire deal negotiation process.
From the moment you select your partner, Medical Device Licensing can help you with initial discussions, preparation of introductory material and suitable deal structure implementation, amongst other things.
Find out more about Deal Negotiation servicesClients in focus...
OTC products ready for registration or in late stage development and molecules with Rx-to-OTC switch potential. More
View more in-licensing opportunities
Elucidation of a Promoter of the Rat Tyrosine Hydroxylase Gene for Tissue Specific Gene Expression
Elucidation of a Promoter of the Rat Tyrosine Hydroxylase Gene for Tissue Specific Gene Expression More
View more out-licensing opportunities
Ethypharm
Generic & Branded Drug Delivery Products More
View more profiled companies